PolyMedix, Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
      • Bioinformatics

Other Names/Subsidiaries

  • PolyMedix Pharmaceuticals, Inc.
See more in Biomedtracker

Latest on PolyMedix, Inc.

Scrip

Deal Watch: Celgene Reworks Alliance With Jounce, Gaining Global Rights To Macrophage-Targeting Candidate

 
• By Joseph Haas, John Davis, Alex Shimmings, Jung Won Shin, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Jounce Gets $50m Up Front As

HBW Insight

Deals of the Week Watches Parkinson’s In Prime Time

 
• By Paul Bonanos, Sten Stovall, Lisa LaMotta, and Jessica Merrill

Parkinson’s disease is about to receive plenty of media attention. Most of that will come as NBC’s “The Michael J. Fox Show” makes its debut Sept. 26, returning its star to center stage in a sitcom th

Pink Sheet

Deals of the Week Watches Parkinson’s In Prime Time

 
• By Paul Bonanos, Sten Stovall, Lisa LaMotta, and Jessica Merrill

Parkinson’s disease is about to receive plenty of media attention. Most of that will come as NBC’s “The Michael J. Fox Show” makes its debut Sept. 26, returning its star to center stage in a sitcom th

Pink Sheet

Cellceutix Buys Mid-Stage Antibiotic Brilacidin On The Cheap

 
• By Jessica Merrill

Cellceutix Corp. is taking advantage of PolyMedix Inc. ’s bankruptcy to acquire the company’s assets at an affordable price and strengthen its own portfolio. Under the arrangement announced Sept.